Clinical Trial Update: Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of Buprenorphine Transdermal System for moderate to severe low back pain was terminated, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• BUPRENORPHINE TRANSDERMAL SYSTEM (buprenorphine)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Back Pain Lower Back Chronic | Phase 3 | Status: TERMINATED | Results posted: 2010-09-29